Treatment patterns, outcomes and health care resource utilisation in patients with metastatic renal cell carcinoma (RCC) - POEM

MSD K.K.0 个研究点目标入组 1,000 人开始时间: 2021年1月18日最近更新: 2023年10月17日

试验速览

暂无简介。

•a.Patient who have any active cancer or undergoing treatment for cancer other than mRCC b.Patient received/about to receive 1L systemic anti-cancer treatment as a clinical trial participant. c.Patient's last adjuvant treatment for RCC was less than 4 weeks (i.e. 28 days) d.Investigator determined the patient to be ineligible due to incomplete medical records at the time of enrolment. Incomplete medical records might be observed for patients who recently transferred to the site without diagnosis or treatment records, or for patients who attended the site only for consultation or second opinion. e.Patients those can be treated with curative intent through either surgical resection and/or percutaneous local therapy will be excluded. a.Patients with transitional cell carcinoma of the renal pelvis or ureter

发起方